govx20130611_8k.htm

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): June 10, 2013

 

GEOVAX LABS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware

 

000-52091

 

87-0455038

(State or other jurisdiction of

incorporation or organization)

 

(Commission File No.)

 

(IRS Employee Identification No.)

 

 

1900 Lake Park Drive, Suite 380

Smyrna, Georgia 30080

(Address of principal executive offices) (Zip code)

 

 

(678) 384-7220

(Registrant’s telephone number, including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions.

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR240.14a-12)

 

[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).

 

[  ] Pre-commencement communications pursuant to Rule 13e-4© under the Exchange Act (17 CFR 240.13(e)-4(c))

 

 
 
 

 

This Form 8-K and other reports filed by GeoVax Labs, Inc. (the “Registrant”) from time to time with the Securities and Exchange Commission (collectively the “Filings”) contain forward looking statements and information that are based upon beliefs of, and information currently available to, the Registrant's management as well as estimates and assumptions made by the Registrant’s management. When used in the Filings the words “anticipate”, “believe”, “estimate”, “expect”, “future”, “intend”, “plan” or the negative of these terms and similar expressions as they relate to the Registrant or the Registrant’s management identify forward looking statements. Such statements reflect the current view of the Registrant with respect to future events and are subject to risks, uncertainties, assumptions and other factors relating to the Registrant’s industry, operations and results of operations and any businesses that may be acquired by the Registrant. Should one or more of these risks or uncertainties materialize, or should the underlying assumptions prove incorrect, actual results may differ significantly from those anticipated, believed, estimated, expected, intended or planned.

 

Item 5.07     Submission of Matters to a Vote of Security Holders.

 

The Company held its annual meeting of the stockholders on June 10, 2013. The Company received proxies totaling approximately 83% of its issued and outstanding shares of common stock representing 17,006,251 shares of common stock, as of the record date of April 11, 2013. The stockholders voted on the following proposals and the results of the voting are presented below.


Election of Directors


Our stockholders approved the slate of directors consisting of five members to hold office until the next annual meeting of stockholders or until their successors are duly elected and qualified. There were a total of 6,305,075 broker non-votes on this item.

 

Nominee

For

Withheld

David A. Dodd

     10,511,303     189,873

Dean G. Kollintzas

     10,495,079     206,097

Robert T. McNally

     10,299,868     401,308

Harriet L. Robinson

     10,563,594     137,582

John N. Spencer, Jr.

     10,519,128     182,048

 

Amendment of Certificate of Incorporation


Our stockholders approved the proposal to amend our certificate incorporation to increase our authorized shares of common stock from 40 million to 75 million. There were no broker non-votes on this item.

 

For

Against

Abstain

 13,801,924

3,186,673

17,654

 

Ratification of Independent Auditor

 

Our stockholders approved the ratification of Porter Keadle Moore LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2013.

 

For

Against

Abstain

16,842,811

63,285

100,155

 

 
2
 

 


 

Advisory Vote on Executive Compensation


Our stockholders approved, on a non-binding advisory basis, the compensation of our named executive officers. There were a total of 6,305,075 broker non-votes on this item.

 

For

Against

Abstain
5,489,135  542,368    4,669,673


Advisory Vote on the Frequency of Future Advisory Votes on Executive Compensation


Our stockholders approved, on a non-binding advisory basis, the frequency of future advisory votes on the compensation of our named executive officers. The determination was to hold such advisory votes on an annual basis. There were a total of 6,305,075 broker non-votes on this item.

 

1 Year    2 Years  3 Years Abstain
7,791,410 89,591   2,695,908  124,267

 

 
3
 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: June 11, 2013

 

 

  GEOVAX LABS, INC.  
       
        
  By: /s/ Mark W. Reynolds  
    Mark W. Reynolds  
    Chief Financial Officer  

 

 

 

 4